throbber
STARCH 1500®
`
`P A R T I A L L Y P R E G E L A T I N I Z E D M A I Z E S T A R C H
`
`Flexibility for performance
`
`C
`
`O
`
`L
`
`O
`
`R
`
`C
`
`O
`
`N
`

`
`Par Pharm., Inc.
`Exhibit 1025
`Page 001
`
`

`

`DIRECT COMPACTION
`
`Starch 1500 performs key functions in
`direct compaction formulations as a binder,
`disintegrant, flow-aid and self-lubricant.
`It also promotes formulation f lexibility
`by complementing and enhancing the
`functionality of other excipients.
`
`B I N D E R
`
`As a dr y binder, it compresses well,
`predominately deforming plastically. Starch
`1500 can be used with other excipients,
`such as microcrystalline cellulose, lactose,
`and dicalcium phosphate, to produce
`tablets with excellent hardness and low
`friability at compaction forces typically
`used in tableting operations.
`
`D I S I N T E G R A N T
`
`Starch 1500 performs the actions of two
`disintegrants; maize starch and free amylose
`in dry processes. In some applications, 2%
`to 10% of Starch 1500 provides disintegrant
`action as effective as super disintegrants,
`greatly reducing costs. (See Figure 1)
`
`Figure 1
`
`DISINTEGRATION PROFILE FOR HYDROCHLOROTHIAZIDE TABLETS, 50 MG **
`
`DISINTEGRATIONTIME(MINUTES)
`
`The combination of maize starch and
`free amylose has a positive impact on
`drug dissolution. Supporting the tablet
`disintegration data in Figure 1, the
`resulting drug dissolution data
`in
`Figure 2 compares Starch 1500 with
`more costly disintegrants.
`
`STARCH 1500 ®
`PARTIALLY PREGELATINIZED MAIZE STARCH
`T H E S U P E R I O R M U LT I F U N C T I O N A L E X C I P I E N T F O R
`
`S O L I D D O S A G E D E V E L O P M E N T
`
`Starch 1500 is a unique pharmaceutical excipient combining
`
`several properties in a single product. Only Starch 1500
`
`performs the multiple functions of a binder, disintegrant,
`
`flow-aid and self-lubricant. It is extremely versatile, being
`
`effective in a variety of processing methods for solid oral
`
`dosage forms. Starch 1500 also exhibits synergy, enhancing
`
`the functionality of other commonly used excipients
`
`in formulations.
`
`MULTIFUNCTIONAL
`Provides a unique range of functions:
`
`• Binder
`• Disintegrant
`• Flow-Aid
`• Lubricant
`
`VERSATILE
`Flexible performance in a variety of applications:
`
`DIRECT
`COMPACTION
`
`WET
`GRANULATION
`
`CAPSULE PLUG
`FORMATION
`
`Binder
`Disintegrant
`Flow-Aid
`Lubricant
`
`X
`X
`X
`X
`
`X
`X
`X*
`X*
`
`X
`X
`X
`X
`
`* In the extra granular phase
`
`COST-EFFECTIVE
`Cuts process and material costs by reducing or eliminating:
`
`• Excess binders
`• Superdisintegrants
`• Additional lubricants and glidants
`• Manufacturing steps
`
`MANUFACTURED FOR THE PHARMACEUTICAL INDUSTRY
`• Manufactured in modern cGMP facilities dedicated solely
`to the production of pharmaceutical excipients
`
`INDUSTRY LEADING TECHNICAL EXPERTISE
`• Worldwide manufacturing, distribution and technical
`service facilities
`
`• Formulation and application development support
`
`• Global regulatory assistance
`
`• Innovative new product development
`
`Par Pharm., Inc.
`Exhibit 1025
`Page 002
`
`

`

`Figure 2
`
`Figure 3
`
`Figure 4
`
`DISSOLUTION PROFILE FOR HYDROCHLOROTHIAZIDE TABLETS, 50 MG**
`
`EJECTION FORCE VALUES FOR HYDROCHLOROTHIAZIDE TABLETS
`
`CONCENTRATION DEPENDENT VISCOSITY PROFILES
`
`VISCOSITY(CP)
`
`EJECTIONFORCE(KN)
`
`% RELEASED
`
`TIME (MIN)
`
`COMPACTION FORCE (KN)
`
`% SOLIDS
`
`** Tablets were formulated with 25%
`hydrochlorothazide, 0.25% magnesium
`stearate, and equal parts lactose and
`dicalcium phosphate. Equal portions of
`the lactose and dicalcium phosphate
`were substituted with 2% or 10%
`Starch 1500.
`
`Hydrochlorothiazide 25%, excipient
`74.75% , 0.25% magnesium stearate
`as lubricant
`
`Traditional starch paste at 85°C
`compared to Starch 1500 and a
`fully pregelatinized starch prepared
`in cold water
`
`F L O W - A I D
`
`Starch 1500 provides excellent f low
`properties, demanded by today’s high-speed
`tableting and capsule filling equipment;
`ensuring that manufacturers can produce
`tablets and capsules with consistent
`uniform weight and drug content.
`
`S E L F L U B R I C A N T
`
`The high inherent lubricity of Starch
`1500 enables the formulator to lower the
`levels of traditional lubricants, such
`as magnesium stearate. For example,
`magnesium stearate added in high levels,
`or when over-blended, can slow dissolution
`and cause problems with compaction
`(soft tablets) and film coating (poor film
`adhesion). Therefore, Starch 1500 enables
`lubricant levels and their potential problems
`to be reduced or eliminated. (See Figure 3)
`
`WET GRANULATION
`
`In wet granulation applications, Starch
`1500 exhibits dual functionality as both
`binder and disintegrant as a result of
`partial cold water solubility. Starch 1500
`allows process flexibility:
`it can be
`dry-blended with other ingredients
`before adding water, or a portion can
`be dispersed in cold water. A slurry of
`Starch 1500 in cold water provides
`effective binding properties at higher
`solids and lower viscosity than traditional
`starch pastes, which must be heated
`and prepared at lower concentrations.
`(See Figure 4) Processing costs are
`reduced by eliminating the time and
`expense of preparing traditional binder
`solutions.
`In addition, granulations
`using Starch 1500 as a binder give
`excellent tablet hardness and fast
`disintegration.
`
`In fluid bed granulations, Starch 1500
`alone can be used as both binder
`a n d d i s i n t e g r a n t . F o r ex a m p l e ,
`capsule-shaped acetaminophen tablets,
`500mg, of excellent hardness and
`friability values of less than 0.19%
`were produced through the simple
`formulation of 85% acetaminophen and
`15% Starch 1500 used as the wet
`granulation binder. In this formulation,
`Starch 1500 functioned as an exceptional
`disintegrant with disintegration time
`less than 1 minute. Dissolution was
`excellent. Test results showed 80% drug
`release within 5 minutes.
`In addition,
`the low viscosity of Starch 1500 in cold
`water allowed higher binder content
`solutions and faster spray times, resulting
`in reduced process times.
`
`Par Pharm., Inc.
`Exhibit 1025
`Page 003
`
`

`

`CAPSULE PLUG FORMATION
`
`Starch 1500, as a f low-aid, improves
`uniformity of capsule fill. As a binder,
`Starch 1500 facilitates plug formation in
`dosator-type equipment and reduces
`powder fallout when the plug is
`transferred. The inherent lubricity of
`Starch 1500 means a lower force to
`eject material into the capsule shell
`(compared to other excipients) and
`leads to reduced wear on dosator-type
`equipment.
`
`C O L O R C O N
`
`S U P P L I E R
`
`O F
`
`C H O I C E
`
`Colorcon has a firm commitment to providing products and
`
`services for high quality coating systems and formulated
`
`products along with technical support dedicated to meeting
`
`STARCH 1500
`PRODUCT RANGE
`
`customers’ needs. In addition, a focus on market issues
`
`and technology development has earned Colorcon an
`
`Colorcon has made Starch 1500 even
`more versatile by developing a line of
`products for optimal performance
`applicable to a variety of formulations.
`The Starch 1500 product range is produced
`exclusively for the pharmaceutical
`industr y under cGMP guidelines.
`Starch 1500 products are designed to
`meet regulator y needs worldwide.
`Specific products conform to the
`USP/NF, Ph.Eur, and JPE compendial
`monographs.A firm
`
`international reputation in the pharmaceutical industry as
`
`the supplier of choice.
`
`Colorcon’s worldwide network of technical service laboratories
`
`and experts bring solutions to our customers when and
`
`where they are needed. These resources serve all aspects
`
`of customer projects including; formulation development,
`
`application development, scale-up support and regulatory
`
`information. We understand the impact of speed to
`
`market in the competitive fast paced pharmaceutical
`
`industry and support our customers in the production
`
`of highly effective formulations in reduced time frames.
`
`Take advantage of our experience, technology and
`
`creativity; enhance your position in the marketplace.
`
`Make Colorcon your partner, your supplier of choice.
`
`Par Pharm., Inc.
`Exhibit 1025
`Page 004
`
`

`

`UNIQUE MANUFACTURING PROCESS
`
`Starch 1500 is a partially pregelatinized maize starch manufactured exclusively for
`
`the pharmaceutical industry in dedicated cGMP facilities. The process involves a
`
`physical modification of the starch (no chemical additives or surfactants are used),
`
`resulting in the combined benefits of the soluble and insoluble functionality of
`
`Starch 1500.
`
`Maize starch is composed of two polymers, amylose and amylopectin which are
`
`tightly bound in a specific spherocrystalline structure. Through partial pregela-
`
`tinization, the bond between a portion of the two polymers is broken, providing
`
`Starch 1500 with its unique properties. The process results in partial solubility,
`
`increased particle size, improved flow properties and compactability.
`
`AMYLOPECTIN
`
`AMYLOSE
`
`Amylopectin has a branched-chain molecular
`structure, which makes it readily soluble
`in cold water. Amylopectin functions as a
`binder in wet granulation processes.
`
`Amylose has a straight-chain molecular
`structure, which exhibits a very strong
`intermolecular bonding capability. Amylose
`swells significantly when wetted, giving it
`excellent disintegrating characteristics.
`
`STARCH NF
`
`STARCH 1500®
`
`ONE EXCIPIENT, MULTIPLE FUNCTIONS
`
`Colorcon’s unique manufacturing process results in the most effective
`
`functional balance for Starch 1500, providing good cold water binding
`
`and granulation properties, yet retaining effective tablet disintegrant
`
`properties. The physical structure of Starch 1500 also imparts good
`
`compactability, flow and lubrication capabilities.
`
`These multifunctional properties can be utilized in a variety of applications,
`
`including direct compaction, wet granulation, fluid bed granulation and
`
`capsule plug formation. The distinct benefits of Starch 1500 can bring
`
`significant process flexibility to solid dosage forms.
`
`SEM photo of Starch 1500 shows individual starch grains along with aggregates bonded to the hydrolyzed starch.
`Starch 1500 has better flow characteristics than Starch NF and has much higher compactability. Photos shown at
`10 microns.
`
`Par Pharm., Inc.
`Exhibit 1025
`Page 005
`
`

`

`STARCH 1500®
`
`P A R T I A L L Y P R E G E L A T I N I Z E D M A I Z E S T A R C H
`
`I Multifunctional for formulation versatility
`
`I Flexibility for performance in a variety of applications
`
`I Manufactured exclusively for the pharmaceutical industry
`
`I Meets global regulatory requirements
`
`WORLD HEADQUARTERS
`COLORCON
`415 Moyer Blvd., P.O. Box 24, West Point, PA 19486-0024
`Tel: 215-699-7733 Fax: 215-661-2605
`
`LOCATIONS
`
`TELEPHONE
`
`FACSIMILE
`
`UNITED STATES
`Santa Ana, California
`Indianapolis, Indiana
`Humacao, Puerto Rico
`
`EUROPE
`Dartford, Kent, England
`Bougival, France
`Idstein, Germany
`Gallarate, Italy
`Budapest, Hungary
`Barcelona, Spain
`
`ASIA/PACIFIC
`Singapore
`Shanghai, China
`Mumbai, India
`Tokyo, Japan
`
`LATIN AMERICA
`Buenos Aires, Argentina
`Bogota, Colombia
`Santa Fe, Mexico
`Caracas, Venezuela
`
`714-549-0631
`317-545-6211
`787-852-3815
`
`714-549-4921
`317-545-6218
`787-852-0030
`
`44-1322-293000
`33-1-3082-1582
`49-6126-9961-0
`39-0331-776932
`36-1-200-8000
`34-9-3589-3756
`
`44-1322-627200
`33-1-3082-7879
`49-6126-9961-11
`39-0331-776831
`36-1-200-8010
`34-9-3589-3792
`
`65-438-0318
`86-21-6489-2222
`91-22-868-2537
`81-3-5248-0581
`
`65-438-0178
`86-21-6489-2223
`91-22-868-4518
`81-3-5248-0547
`
`54-11-4552-1565
`571-418-1202
`525-292-1611
`58-2-442-4819
`
`54-11-4552-5158
`571-418-1190
`525-292-1750
`58-2-442-6340
`
`VISIT COLORCON ONLINE AT www.colorcon.com
`
`The information contained herein, to the best of our knowledge, is true and
`accurate. Any recommendations or suggestions are made without warranty or
`guarantee, since the conditions of use are beyond our control. Any information
`contained herein is intended as a recommendation for use of our products so as
`not to infringe on any patent.
`
`Starch 1500® is a trademark of BPSI.
`©1999 Colorcon
`
`EX/STAR/PB1199
`
`Colorcon’s globally available product line for the pharmaceutical
`industry includes:
`
`Complete Film Coating Systems
`Opadry®
`Opadry® II
`Opadry® AMB
`
`Modified Release Products
`Sureteric® Aqueous Enteric Coating System
`Surelease® Aqueous Ethylcellulose Dispersion
`
`Monogramming Inks
`Opacode®
`Opacode® WB
`
`Excipients
`Starch 1500® Partially Pregelatinized Maize Starch
`
`Additional Products
`Opaspray® Color Coating Dispersion
`Opatint® Food Coloring System
`Opaseal® Sealant Coating Product
`Opaglos® Tablet Core Sealant Product
`Opalux® Color Coating Product
`
`FD&C and D&C Aluminium Lakes
`
`Pigment Blends
`
`Member of the Berwind Pharmaceutical Group
`
`Par Pharm., Inc.
`Exhibit 1025
`Page 006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket